Healthcare Realty Trust Incorporated (HR)
NYSE: HR · Real-Time Price · USD
16.76
0.00 (0.00%)
At close: Mar 28, 2025, 4:00 PM
16.75
-0.01 (-0.08%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Healthcare Realty Trust Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Healthcare Realty Trust stock have an average target of 17, with a low estimate of 16 and a high estimate of 19. The average target predicts an increase of 1.43% from the current stock price of 16.76.
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Healthcare Realty Trust stock from 5 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 5 | 4 | 2 | 2 |
Sell | 1 | 1 | 1 | 2 | 2 | 3 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 6 | 6 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Sell Maintains $17 → $16 | Sell | Maintains | $17 → $16 | -4.53% | Mar 10, 2025 |
Scotiabank | Scotiabank | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | +1.43% | Feb 25, 2025 |
Wedbush | Wedbush | Hold → Sell Downgrades $18 → $16 | Hold → Sell | Downgrades | $18 → $16 | -4.53% | Jan 2, 2025 |
JP Morgan | JP Morgan | Buy → Hold Downgrades $19 | Buy → Hold | Downgrades | $19 | +13.37% | Dec 20, 2024 |
Wells Fargo | Wells Fargo | Sell Initiates $16 → $17 | Sell | Initiates | $16 → $17 | +1.43% | Oct 1, 2024 |
Financial Forecast
Revenue This Year
1.26B
from 1.27B
Decreased by -0.65%
Revenue Next Year
1.30B
from 1.26B
Increased by 3.10%
EPS This Year
-0.40
from -1.81
EPS Next Year
-0.39
from -0.40
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 1.3B | 1.4B | 1.2B | |
Avg | 1.3B | 1.3B | 1.2B | |
Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 4.0% | 8.7% | -4.0% | |
Avg | -0.6% | 3.1% | -5.8% | |
Low | -10.9% | -9.2% | -10.4% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.29 | -0.30 |
Avg | -0.40 | -0.39 |
Low | -0.46 | -0.44 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.